Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71335-2618

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71335-2618). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\ra\desktop\1.jpg (5a5eca60 Figure 01)

This text provides a list of blood pressure readings at baseline before administering different medications. It shows the blood pressure goal (SBP <140 mmHg) and the milligrams of each medication to be given. The medications listed are Valsartan-HCTZ 320/125 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The baseline SBP readings include values from 140 to 180 mmHg.*

FDA Label Image

C:\users\ra\desktop\2.jpg (5a5eca60 Figure 02)

This text appears to be providing information on blood pressure readings before and after treatment with Valsartan-HCTZ, a combination medication containing 320 mg of Valsartan and 25 mg of Hydrochlorothiazide. The baseline diastolic blood pressure (DBP) is recorded at 105 mmHg and is aimed to be reduced to below 90 mmHg. A placebo group is also mentioned.*

FDA Label Image

C:\users\ra\desktop\3.jpg (5a5eca60 Figure 03)

This text provides information on different blood pressure levels (mmHg) for a study comparing Valsartan-HCTZ 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. Baseline SBP (mmHg) ranges from 140 to 180.*

FDA Label Image

C:\users\ra\desktop\4.jpg (5a5eca60 Figure 04)

This text provides information about blood pressure (BP) measurements for different treatment groups. The readings indicate BP levels below 80 mmHg for a particular group receiving Valsartan-HCTZ 320/25 mg. Another group received Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. Baseline DBP (mmHg) measurements of 100 and 105 are mentioned for comparison purposes.*

FDA Label Image

C:\users\ra\desktop\5.jpg (5a5eca60 Figure 05)

FDA Label Image

C:\users\ra\desktop\6.jpg (5a5eca60 Figure 06)

FDA Label Image

Label (Lbl713352618)

Each tablet contains 80 mg of Valsartan USP and 12.5 mg of Hydrochlorothiazide USP. This medication should be stored at a temperature of 20° to 25°C (68° to 77°F). Pharmacists are advised to dispense the medication guide with each Hydrochlorothiazide tablet. The tablets should be kept in a tight container to protect them from moisture. Ensure the medication is kept out of reach of children. The National Drug Code (NDC) for this tablet is 71335-2618_1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.